Mobile

Efficacy and safety of agomelatine (25mg/day with blinded potential adjustment to 50mg/day) versus escitalopram (10mg/day with blinded potential adjustment to 20mg/day) given orally for 12 weeks in no...

Mise à jour : Il y a 4 ans
Référence : EUCTR2012-003699-37

Efficacy and safety of agomelatine (25mg/day with blinded potential adjustment to 50mg/day) versus escitalopram (10mg/day with blinded potential adjustment to 20mg/day) given orally for 12 weeks in non-depressed out-patients with severe Generalized Anxiety Disorder

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

To assess the efficacy of agomelatine compared to escitalopram after a 12-week treatment in non-depressed out-patients suffering from severe Generalized Anxiety Disorder (GAD).

Critère d'inclusion

  • Generalized Anxiety Disorder

Liens